Chicago Cubs starting pitcher Cade Horton will undergo season-ending elbow surgery to repair a strained ulna collateral ligament, manager Craig Counsell confirmed. The procedure type—either a full Tommy John reconstruction or internal brace repair—remains uncertain until surgeons operate. Horton, 24, was placed on the 15-day injured list Sunday after leaving Friday’s game against the Cleveland Guardians with diminished velocity, dropping from 96 mph to 93.8 mph on a fastball. Dr. Keith Meister in Arlington, Texas, diagnosed the injury, which follows Horton’s history of elbow and shoulder issues, including prior Tommy John surgery as a college freshman. Craig Counsell emphasized the blow to the Cubs’ rotation, noting Horton’s strong 2025 campaign: 11-4 record, 2.67 ERA, and 4 strikeouts in 7⅓ innings across two starts this season.

Horton’s injury compounds challenges for the Cubs, who already lost left-hander Matthew Boyd to a biceps strain. Replacements like Javier Assad and Colin Rea lack Horton’s pitching prowess, forcing the team to reshuffle roles. Counsell stated, “Colin’s going to be asked to pitch more innings out of the bullpen,” while acknowledging the broader roster adjustments needed. The Cubs also anticipate lefty Justin Steele’s return from elbow surgery, with a projected June major league debut.

Horton’s career trajectory hinges on recovery success, though his injury-prone nature raises durability concerns. The Cubs’ front office faces pressure to bolster pitching depth before the trade deadline. Meanwhile, Horton’s absence weakens Chicago’s playoff aspirations, as his fastball and strikeout rate ranked among the NL’s top 10 starters this season.

Season-ending injury reshapes the Cubs’ 2025 outlook, testing their ability to adapt without their emerging ace. Rosters will prioritize durability over raw talent in the short term, but long-term success depends on Horton’s rehabilitation timeline and the organization’s offseason moves.